ShareValue scores for IATR.AT: Valuation 47, Quality 25, Growth 46, Health 35.

IATR.AT
ATHEX

Athens Medical C.S.A.

€1.65(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

2% to 17%
Valuation
47
Fair Value
Price vs Value
Quality
25
Weak
Business Strength
Growth
46
Moderate
Revenue & Earnings
Health
35
Stressed
Financial Stability
Momentum
46
Neutral
Price Trend

Company Details

About

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injuries; plastic Surgeries for face, body, breast, obesity, reconstructive plastic surgery, scar correction, and sex reassignment; bariatric surgery for gastric banding, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch; and chronic diseases, including diabetes, endocrinology, heat failure, high blood pressure, pain management, respiratory system, stroke, and thyroid conditions. In addition, the company operates wellness and prevention centers; and offers medical education, training, and practice services. The company was founded in 1983 and is based in Athens, Greece.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026